Peptide Therapeutics Market Manufacturers Analysis, Trends, Segment and Application up to 2025
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Peptide</strong> <strong>Therapeutics</strong> <strong>Market</strong> <strong>Manufacturers</strong> <strong>Analysis</strong>, <strong>Trends</strong>,<br />
<strong>Segment</strong> <strong>and</strong> <strong>Application</strong> <strong>up</strong> <strong>to</strong> <strong>2025</strong><br />
“<strong>Peptide</strong> <strong>Therapeutics</strong> <strong>Market</strong> is predicted <strong>to</strong> reach USD 48.04<br />
billion by <strong>2025</strong> owing <strong>to</strong> rise in dem<strong>and</strong> for efficient & speedy<br />
treatment of cancer <strong>and</strong> other lifestyle-related disorders.<br />
<strong>Peptide</strong>s are the naturally occurring biological molecules that are<br />
used in drugs <strong>to</strong> improve the patient’s medical condition.”<br />
Global <strong>Peptide</strong> <strong>Therapeutics</strong> <strong>Market</strong> is predicted <strong>to</strong> reach USD 48.04 billion by <strong>2025</strong> owing <strong>to</strong> rise in dem<strong>and</strong><br />
for efficient & speedy treatment of cancer <strong>and</strong> other lifestyle-related disorders. <strong>Peptide</strong>s are the naturally<br />
occurring biological molecules that are used in drugs <strong>to</strong> improve the patient’s medical condition. They are highly<br />
safe <strong>and</strong> effective due <strong>to</strong> which they are widely accepted by physicians <strong>and</strong> patients for treating several ailments.<br />
In the medical practice, they are ideal for diabetes, infectious diseases, several type of cancers, cardiovascular<br />
<strong>and</strong> other medical conditions. <strong>Peptide</strong>s are highly modifiable <strong>and</strong> versatile in comparison <strong>to</strong> other drugs, which<br />
make them highly profitable <strong>to</strong> sponsors. Due <strong>to</strong> their feature of versatility, they are used in multiple medical<br />
conditions that leads <strong>to</strong> higher penetration of peptide therapeutics industry.<br />
Along with the growing prevalence of cardiovascular disorders <strong>and</strong> cancers, the increasing research &<br />
development activities <strong>and</strong> rich peptide therapeutics pipeline are predicted <strong>to</strong> s<strong>up</strong>port the growth of the market<br />
in near future. The patent expiration of various peptide drugs in future is expected <strong>to</strong> create ample opportunities<br />
for the market contributing <strong>to</strong> its growth at a significant rate.<br />
<strong>Peptide</strong> therapeutics have application in CNS (Central Nervous System) disorders <strong>and</strong> respira<strong>to</strong>ry disorders due<br />
<strong>to</strong> features like safe, efficiency <strong>and</strong> versatility. Advanced research & development facilities <strong>and</strong> new peptide<br />
developments by pharma companies are driving the dem<strong>and</strong> for reasonably priced peptide therapeutics.<br />
Get a Sample Copy of This Report @<br />
https://www.millioninsights.com/industry-reports/peptide-therapeutics-market/request-sample
Nevertheless, the large scale production of peptide with increasing complexities of peptides is a major challenge<br />
for peptide therapeutics market. The development of multifunctional peptides <strong>and</strong> rise in number of<br />
collaboration for the progress of peptide conjugates are currently ruling the market.<br />
Latest advances in peptide synthesis technology is projected <strong>to</strong> be the key driver for the growth of peptide<br />
therapeutics industry. From among the different methods of peptide synthesis, enzymatic <strong>and</strong> chemical<br />
synthesis are important. This technology has integrated structure-activity relationships (SARs) <strong>and</strong> analog<br />
generation <strong>to</strong> increase bioavailability, increase safety & efficacy of drugs, impart protease resistance, reduce<br />
adverse effects, <strong>and</strong> develop formulations.<br />
Browse Full Research Report @<br />
https://www.millioninsights.com/industry-reports/peptide-therapeutics-market<br />
The other driving fac<strong>to</strong>r of the market is the shift <strong>to</strong>wards unexploited market. The market is witnessing several<br />
vendors focusing on developing economies due <strong>to</strong> presence of large population gro<strong>up</strong>s <strong>and</strong> clinical trial subjects.<br />
Fac<strong>to</strong>rs like presence of lenient regula<strong>to</strong>ry guidelines, skilled labor, limited market competition, <strong>and</strong> low<br />
manufacturing costs will encourage vendors <strong>to</strong> shift their manufacturing processes <strong>to</strong> the developing<br />
economies.<br />
<strong>Peptide</strong> therapeutics market is categorized on the basis of application, technology, route of administration,<br />
molecule type, API peptide type, <strong>and</strong> geography. On the basis of application, the market is divided in<strong>to</strong> Cancer,<br />
Metabolic, CVD, Respira<strong>to</strong>ry, GIT, Anti-infective, Derma<strong>to</strong>logy, CNS, Renal, etc. In terms of route of<br />
administration, the market is segmented as Parenteral, Oral, etc.<br />
On the basis of type, peptide therapeutics industry is divided in<strong>to</strong> Innovative <strong>and</strong> Generic. On the basis of<br />
technology, the market is classified in<strong>to</strong> Liquid Phase, Solid Phase, <strong>and</strong> Hybrid Phase. Type of Molecule is<br />
classified in<strong>to</strong> Vasopressin, Soma<strong>to</strong>statin, Calci<strong>to</strong>nin, Immunopeptide, Natriuretic, <strong>and</strong> others. On the basis of<br />
API <strong>Peptide</strong> Type, the market is divided in<strong>to</strong> In-house, <strong>and</strong> CMO (contract manufacturing organization).<br />
Geographically, peptide therapeutics market is segmented as North America, Latin America, Europe, Asia Pacific,<br />
<strong>and</strong> Middle East & Africa. North America <strong>and</strong> Latin America are predicted <strong>to</strong> hold larger share of the market<br />
owing <strong>to</strong> the rising incidences of cancer <strong>and</strong> other life-style related disorders.<br />
The key peptide therapeutics industry players comprise AstraZeneca plc, Amgen Inc., Eli Lilly <strong>and</strong> Company,<br />
Sanofi, CordenPharma International GmbH, Teva Pharmaceutical Industries Ltd., Novartis AG, Ipsen S.A., Lonza<br />
Gro<strong>up</strong> Ltd., Merck & Co. Inc., F. Hoffmann-La Roche AG, Bachem Holding AG, Poly<strong>Peptide</strong> Gro<strong>up</strong> <strong>and</strong> Novo<br />
Nordisk A/S.<br />
<strong>Market</strong> <strong>Segment</strong>:<br />
<strong>Peptide</strong> <strong>Therapeutics</strong>, <strong>Application</strong> Outlook (Revenue, USD Million; 2014 - <strong>2025</strong>)
• Cancers<br />
• Metabolic<br />
• Cardiovascular Disorder<br />
• Respira<strong>to</strong>ry<br />
• GIT<br />
• Antiinfection<br />
• Pain<br />
• Derma<strong>to</strong>logy<br />
• CNS<br />
• Renal<br />
• Others<br />
<strong>Peptide</strong> <strong>Therapeutics</strong>, Type Outlook (Revenue, USD Million; 2014 - <strong>2025</strong>)<br />
• Generic<br />
• Innovative<br />
<strong>Peptide</strong> <strong>Therapeutics</strong>, Type of <strong>Manufacturers</strong> Outlook (Revenue, USD Million; 2014 - <strong>2025</strong>)<br />
• In-house<br />
• Outsourced<br />
<strong>Peptide</strong> <strong>Therapeutics</strong>, Route of Administration Outlook (Revenue, USD Million; 2014 - <strong>2025</strong>)<br />
• Parenteral Route<br />
• Oral Route<br />
• Pulmonary<br />
• Mucosal<br />
• Others
<strong>Peptide</strong> <strong>Therapeutics</strong>, Synthesis Technology Outlook (Revenue, USD Million; 2014 - <strong>2025</strong>)<br />
• Solid Phase <strong>Peptide</strong> Synthesis (SPPS)<br />
• Liquid Phase <strong>Peptide</strong> Synthesis (LPPS)<br />
• Hybrid Technology<br />
<strong>Peptide</strong> <strong>Therapeutics</strong>, Regional Outlook (Revenue, USD Million; 2014 - <strong>2025</strong>)<br />
• North America<br />
• U.S.<br />
• Canada<br />
• Europe<br />
• Germany<br />
• UK<br />
• Asia Pacific<br />
• China<br />
• Japan<br />
• India<br />
• Latin America<br />
• Mexico<br />
• Brazil<br />
• MEA<br />
• South Africa
See More Reports of this Category by Million Insights @<br />
https://www.millioninsights.com/industry/pharmaceuticals<br />
Get in <strong>to</strong>uch<br />
At Million Insights, we work with the aim <strong>to</strong> reach the highest levels of cus<strong>to</strong>mer satisfaction. Our<br />
representatives strive <strong>to</strong> underst<strong>and</strong> diverse client requirements <strong>and</strong> cater <strong>to</strong> the same with the<br />
most innovative <strong>and</strong> functional solutions.<br />
Contact Person:<br />
Ryan Manuel<br />
Research S<strong>up</strong>port Specialist, USA<br />
Email: ryan@millioninsights.com<br />
Global Headquarters<br />
Million Insights<br />
Fel<strong>to</strong>n Office Plaza 6265 Highway 9 Fel<strong>to</strong>n, California 95018, United States<br />
Phone: 1-408-610-2300<br />
Email: sales@millioninsights.com<br />
Asia Pacific<br />
Million Insights<br />
Office No. 302, 3rd Floor, Manikch<strong>and</strong> Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016<br />
India<br />
Phone: 91-20-65300184
Change language